Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04507451
Other study ID # RESP-USI
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 1, 2020
Est. completion date September 1, 2023

Study information

Verified date November 2020
Source University of Liege
Contact Anne-Françoise Rousseau, MD, PhD
Phone +3243667495
Email afrousseau@chuliege.be
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Respiratory muscle weakness is common after mechanical ventilation and occurs early. This can limit functional recovery. Respiratory muscle training is often neglected in clinical practice. Some data indicates that inspiratory muscle training increases inspiratory muscle strength and quality of life. The aim of the study is to assess the impact of combined inspiratory and expiratory muscle training on inspiratory muscle strength. The second aim is to assess the impact of this training program on expiratory muscle strength.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date September 1, 2023
Est. primary completion date September 1, 2023
Accepts healthy volunteers No
Gender Male
Age group 18 Years and older
Eligibility Inclusion Criteria: - patient from mechanical ventilation after at least 24 hours of support - collaborative patient Exclusion Criteria: - confusion, mental disorder - not french speaking - pulmonary surgery in the past 12 months - external ventricular drain - previous pneumothorax or pneumothorax not drained - rib fractures - alveolar hemorrhage - hemodynamic instability - labial occlusion impossible (face burn, facial paralysis) - patient refusal

Study Design


Intervention

Procedure:
inspiratory and expiratory muscle training
inspiratory muscle training using threshold IMT device expiratory muscle training using a bottle filled of water
inspiratory and expiratory exercises
inspiratory exercise using fractionated inspirations expiratory exercise using a bottle filled with water at a minimum level

Locations

Country Name City State
Belgium University Hospital of Liège Liège

Sponsors (1)

Lead Sponsor Collaborator
University of Liege

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary change in inspiratory muscle strength measurement of maximal inspiratory pressure between 7 to 15 days after ICU discharge (compared to ICU discharge)
Primary change in inspiratory muscle strength measurement of maximal inspiratory pressure 1 month after ICU discharge (compared to ICU discharge)
Secondary change in expiratory muscle strength measurement of maximal expiratory pressure between 7 to 15 days after ICU discharge (compared to ICU discharge)
Secondary change in expiratory muscle strength measurement of maximal expiratory pressure 1 month after ICU discharge (compared to ICU discharge)
Secondary respiratory infections number of respiratory infections requiring antibiotics after ICU discharge 1 month after ICU discharge
Secondary change in dyspnea perception assessed using Dyspnea-12 questionnaire (score from 0 to 36, 36 indicating a maximal dyspnea) 1 month after ICU discharge (compared to hospital discharge)
Secondary impact of dyspnea on physical activities assessed using modified Medical Research Council (m-MRC) score: stage 0 to 4 (last stage indicating a patient too dyspneic to leave house or breathless when dressing) between 7 to 15 days after ICU discharge
Secondary impact of dyspnea on physical activities assessed using modified Medical Research Council (m-MRC) score: stage 0 to 4 (last stage indicating a patient too dyspneic to leave house or breathless when dressing) 1 month after ICU discharge
See also
  Status Clinical Trial Phase
Completed NCT04551508 - Delirium Screening 3 Methods Study
Recruiting NCT06037928 - Plasma Sodium and Sodium Administration in the ICU
Completed NCT03671447 - Enhanced Recovery After Intensive Care (ERIC) N/A
Recruiting NCT03941002 - Continuous Evaluation of Diaphragm Function N/A
Recruiting NCT04674657 - Does Extra-Corporeal Membrane Oxygenation Alter Antiinfectives Therapy Pharmacokinetics in Critically Ill Patients
Completed NCT04239209 - Effect of Intensivist Communication on Surrogate Prognosis Interpretation N/A
Completed NCT05531305 - Longitudinal Changes in Muscle Mass After Intensive Care N/A
Terminated NCT03335124 - The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock Phase 4
Completed NCT02916004 - The Use of Nociception Flexion Reflex and Pupillary Dilatation Reflex in ICU Patients. N/A
Recruiting NCT05883137 - High-flow Nasal Oxygenation for Apnoeic Oxygenation During Intubation of the Critically Ill
Completed NCT04479254 - The Impact of IC-Guided Feeding Protocol on Clinical Outcomes in Critically Ill Patients (The IC-Study) N/A
Recruiting NCT04475666 - Replacing Protein Via Enteral Nutrition in Critically Ill Patients N/A
Not yet recruiting NCT04538469 - Absent Visitors: The Wider Implications of COVID-19 on Non-COVID Cardiothoracic ICU Patients, Relatives and Staff
Not yet recruiting NCT04516395 - Optimizing Antibiotic Dosing Regimens for the Treatment of Infection Caused by Carbapenem Resistant Enterobacteriaceae N/A
Withdrawn NCT04043091 - Coronary Angiography in Critically Ill Patients With Type II Myocardial Infarction N/A
Recruiting NCT02989051 - Fluid Restriction Keeps Children Dry Phase 2/Phase 3
Recruiting NCT02922998 - CD64 and Antibiotics in Human Sepsis N/A
Completed NCT02899208 - Can an Actigraph be Used to Predict Physical Function in Intensive Care Patients? N/A
Completed NCT03048487 - Protein Consumption in Critically Ill Patients
Recruiting NCT02163109 - Oxygen Consumption in Critical Illness